ATNM
Actinium Pharmaceuticals, Inc. · AMEX
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website actiniumpharma.com
- Employees(FY) 49
- ISIN US00507W2061
Performance
+10.11%
1W
+26.61%
1M
+53.85%
3M
+115.86%
6M
+92.91%
YTD
+16.81%
1Y
Profile
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted radiotherapies to deliver cancer-killing radiation to treat patients with high unmet medical needs. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for bone marrow transplant conditioning; and a Phase I study with a CD19- targeted CAR T-cell therapy with memorial sloan kettering cancer center. The company also offers clinical and preclinical development programs that utilize multiple isotopes, including Actinium-225, Iodine-131, and Lutetium-177 directed at multiple targets in oncology and hematology, including CD45, CD33, HER3, and other. It has collaboration with Astellas Pharma, Inc. to develop theranostics for solid tumor indications; EpicentRx, Inc that focuses on a novel CD47 immunotherapy targeted radiotherapy; and AVEO Oncology that focuses on developing a HER3 targeting ARC for solid tumors. The company is based in New York, New York.
Technical Analysis of ATNM 2024-05-10
Overview:
In analyzing the technical indicators for ATNM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-14 20:30
- 2024-05-14 06:38
- 2024-05-13 19:46
- 2024-05-12 20:30
- 2024-05-06 20:00
- 2024-04-17 20:00
- 2024-04-15 00:54
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential(Yahoo Finance)
- 2024-03-31 20:00
- 2024-03-25 19:18
- 2024-03-14 18:15
- 2024-03-10 19:30
- 2024-02-25 18:30
- 2024-02-25 00:37
- 2024-02-22 18:30
- 2024-01-01 18:30
- 2023-12-10 19:15
- 2023-12-10 18:45
- 2023-12-07 19:00
- 2023-11-05 18:30
- 2023-11-02 04:15
Actinium Pharmaceuticals to Attend Bio-Europe Munich 2023(Yahoo Finance)
- 2023-11-01 21:05
- 2023-10-30 20:15
Neurocrine Biosciences (NBIX) Q3 Earnings Miss Estimates(Yahoo Finance)
- 2023-10-03 19:30
- 2023-09-26 21:05
- 2023-09-06 20:40
- 2023-08-30 19:00
- 2023-08-20 19:00
- 2023-08-14 21:41
Actinium: Q2 Earnings Snapshot(Yahoo Finance)
- 2023-07-23 19:00
- 2023-06-25 19:00
Page 1 of 4
previousnext